Enzo Biochem Overview
- Year Founded
-
1976
- Status
-
Private
- Employees
-
177
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
5
- Investments
-
4
Enzo Biochem General Information
Description
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.
Contact Information
Website
www.enzo.comCorporate Office
- 21 Executive Boulevard
- Farmingdale, NY 11735
- United States
Corporate Office
- 21 Executive Boulevard
- Farmingdale, NY 11735
- United States
Enzo Biochem Timeline
Enzo Biochem Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Enzo Biochem Comparisons
Industry
Financing
Details
Enzo Biochem Competitors (43)
One of Enzo Biochem’s 43 competitors is Xencor, a Formerly VC-backed company based in Pasadena, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Xencor | Formerly VC-backed | Pasadena, CA | ||||
| Genetix Biotherapeutics | Private Equity-Backed | Somerville, MA | ||||
| Melior Discovery | Venture Capital-Backed | Exton, PA | ||||
| GSK | Corporation | London, United Kingdom | ||||
| Roche | Corporation | Basel, Switzerland |
Enzo Biochem Patents
Enzo Biochem Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4588924-A1 | Phosphoramidite compounds and methods for preparing synthetic nucleic acids | Inactive | 17-Jan-2024 | ||
| US-20250230179-A1 | Phosphoramidite compounds and methods for preparing synthetic nucleic acids | Pending | 17-Jan-2024 | ||
| US-20250336488-A1 | Blockchain-based biological sample storage | Inactive | 12-May-2022 | ||
| WO-2023220229-A1 | Blockchain-based biological sample storage | Inactive | 12-May-2022 | ||
| CA-3224437-A1 | Method for detecting and quantifying dna methylation in a selected locus or region of dna | Pending | 02-Jul-2021 | C12Q1/708 |
Enzo Biochem Signals
Enzo Biochem Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Enzo Biochem Investments & Acquisitions (4)
Enzo Biochem’s most recent deal was a Corporate Asset Purchase with 36,000 square feet Commercial Facility in Farmingdale for . The deal was made on 24-Jan-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 36,000 square feet Commercial Facility in Farmingdale | 24-Jan-2019 | Corporate Asset Purchase | Buildings and Property | ||
| Assay Designs | 12-Mar-2009 | Merger/Acquisition | Buildings and Property | ||
| Biomol (Distributors/Wholesale) | 08-May-2008 | Merger/Acquisition | Distributors (Healthcare) | ||
| OraGen | 26-Feb-2004 | Merger/Acquisition | Biotechnology |
Enzo Biochem Exits (1)
Enzo Biochem’s most recent exit was on 08-May-2008 from Biomol (Distributors/Wholesale). The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Biomol (Distributors/Wholesale) | 08-May-2008 | Completed |
|
Enzo Biochem FAQs
-
When was Enzo Biochem founded?
Enzo Biochem was founded in 1976.
-
Where is Enzo Biochem headquartered?
Enzo Biochem is headquartered in Farmingdale, NY.
-
What is the size of Enzo Biochem?
Enzo Biochem has 177 total employees.
-
What industry is Enzo Biochem in?
Enzo Biochem’s primary industry is Biotechnology.
-
Is Enzo Biochem a private or public company?
Enzo Biochem is a Private company.
-
What is the current valuation of Enzo Biochem?
The current valuation of Enzo Biochem is .
-
What is Enzo Biochem’s current revenue?
The current revenue for Enzo Biochem is .
-
How much funding has Enzo Biochem raised over time?
Enzo Biochem has raised $15.6M.
-
Who are Enzo Biochem’s investors?
Battery Ventures has invested in Enzo Biochem.
-
Who are Enzo Biochem’s competitors?
Xencor, Genetix Biotherapeutics, Melior Discovery, GSK, and Roche are some of the 43 competitors of Enzo Biochem.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process